The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2024 | Advancing our understanding of resistance mechanisms to anti-BCMA therapies in multiple myeloma
In this video, Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses recent advances in understanding resistance mechanisms in patients with multiple myeloma who progress on anti-BCMA therapies. Dr Raje highlights that studies are exploring the role of antigen loss, sequencing, and microenvironmental factors, and notes that while some resistance mechanisms are well understood, others are still being studied. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
